Loss of Sour Taste Is the Striking Feature among Four Basic Taste Qualities in Tunisian COVID-19 Patients
Authors:
- Inchirah KarmousIKInchirah Karmous
- Amira Sayed KhanAKAmira Sayed Khan
- Imen SahnounISImen Sahnoun
- Rym Ben OthmanRym Ben Othman
- Houda Ben JemaaHJHouda Ben Jemaa
- Faten MahjoubFMFaten Mahjoub
- Amel GamoudiAGAmel Gamoudi
- Leila Douik El GharbiLGLeila Douik El Gharbi
- Tahar MestiriTMTahar Mestiri
- Naim Akhtar KhanNaim Akhtar Khan
- Henda JamoussiHJHenda Jamoussi
Open Access
- 11 January 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 597
Abstract
Background: Taste disorders (TDs) have been reported to be very common in patients suffering from coronavirus disease 2019 (COVID-19), which is caused by the SARS-CoV-2 virus. In most of the hitherto conducted studies, a gustatory assessment was performed on the basis of surveys or self-reports by patients. The aim of our study was to undertake an objective assessment of four basic taste qualities by conducting tasting sessions that allowed detection thresholds in COVID-19 Tunisian patients and to study their associations with inflammation. Methods: This analytical cross-sectional study was conducted on 89 patients aged between 21 to 70 years who had been diagnosed with COVID-19. We used Burghart taste strips to assess taste perception of the four taste qualities, i.e., sour, bitter, sweet, and salty. Serum levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and C-reactive protein (CRP) were measured. Results: Taste disorders were reported by 40.4% of the patients, while objective assessments revealed that 63.8% of participants were suffering from hypogeusia and/or ageusia. Sour taste was the most altered (70.8%) gustatory quality. Patients with severe COVID-19 had significantly lower sour and bitter taste scores when compared to patients with minor/moderate forms. There was no significant association between serum inflammatory markers and taste disorders. However, the relationship between bitter and sweet taste qualities and IL-1β levels was significant (p = 0.018 and p = 0.041). Conclusions: Our results demonstrate the interest in the objective assessment of taste dysfunctions in COVID-19 patients.Keywords
This publication has 43 references indexed in Scilit:
- Potential pathogenesis of ageusia and anosmia in COVID‐19 patientsInternational Forum of Allergy & Rhinology, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Objective evaluation of anosmia and ageusia in COVID‐19 patients: Single‐center experience on 72 casesHead & Neck, 2020
- Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European studyEuropean Archives of Oto-Rhino-Laryngology, 2020
- Chemosensory Dysfunction in Alcohol-Related Disorders: A Joint Exploration of Olfaction and TasteChemical Senses, 2015
- Genetics of Taste ReceptorsCurrent Pharmaceutical Design, 2014
- Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)BMJ Open, 2012
- The influence of hypotensive drugs on the taste sensitivity in patients with primary hypertension.2012
- “Taste Strips” – A rapid, lateralized, gustatory bedside identification test based on impregnated filter papersJournal of Neurology, 2009
- Quantitative assessment of gustatory function in a clinical context using impregnated "taste strips".2003